A carregar...

Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma

PURPOSE: Genetically-targeted therapies are both promising and costly advances in the field of oncology. Several treatments for metastatic melanoma with a mutation in the BRAF gene have been approved. They extend life but are more expensive than the previous standard of care (dacarbazine). Vemurafen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Curl, Patti, Vujic, Igor, van ‘t Veer, Laura J., Ortiz-Urda, Susana, Kahn, James G.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4157865/
https://ncbi.nlm.nih.gov/pubmed/25198196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0107255
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!